{
    "2019-05-11": [
        [
            {
                "time": "",
                "original_text": "华大基因强调关联交易所带来的合规性，加大研发甩掉销售公司帽子",
                "features": {
                    "keywords": [
                        "华大基因",
                        "关联交易",
                        "合规",
                        "加大研发",
                        "销售公司"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "研发投入增长51%，华大基因归核创新驱动",
                "features": {
                    "keywords": [
                        "研发投入",
                        "增长",
                        "华大基因",
                        "创新驱动"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物科技",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}